[EN] MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR<br/>[FR] MODULATEURS DU RÉGULATEUR DE LA CONDUCTANCE TRANSMEMBRANAIRE DE LA MUCOVISCIDOSE
申请人:VERTEX PHARMA
公开号:WO2022076625A1
公开(公告)日:2022-04-14
This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) having core structure (I), pharmaceutical compositions containing at least one such modulator, methods of treatment of CFTR mediated diseases, including cystic fibrosis, using such modulators and pharmaceutical compositions, combination pharmaceutical compositions and combination therapies, and processes and intermediates for making such modulators.
本发明提供了囊性纤维化跨膜传导调节因子(CFTR)的调节剂,其具有核心结构(I),包含至少一种这样的调节剂的制药组合物,使用这样的调节剂和制药组合物治疗CFTR介导的疾病,包括囊性纤维化,组合制药组合物和组合疗法,以及制造这样的调节剂的过程和中间体。